Research.Patient.info
Hepatocellular Carcinoma research hub
2 indexed studies · 0 currently recruiting
- active not recruitingPHASE1, PHASE2
BOXR1030 T Cells in Subjects With Advanced GPC3-Positive Solid Tumors
This study is testing a new cell therapy called BOXR1030 for advanced cancers like liver, lung, and certain other solid tumours. It aims to see how safe it is and find the best dose.
United States · United Kingdom - authorisedHuman Pharmacology (Phase I)- First administration to humans
EPITOME-1015-I: A phase I study to investigate the safety and tolerability of MDG1015 in patients with epithelial ovarian cancer, gastroesophageal adenocarcinoma, round cell liposarcoma and/or synovial sarcoma
This study is testing a new medicine, MDG1015, for the first time in people. It aims to see if it's safe and how well people tolerate it. The study is for certain types of cancer: ovarian, stomach/gullet, and two types of soft tissue sarcoma.
Netherlands